1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow ONC-PluReceptor NK cells: new trials by email Literature Review of ONC-PluReceptor NK cells trials Research Report on ONC-PluReceptor NK cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma ONC-PluReceptor NK cells - Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 30 | 2026-02-24 | 2026-11-03 |
Lymphoma, B-Cell (1)
M.D. Anderson Cancer Center (1)
United States (1)